Barcelona, Spain

Juana Diez

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2009.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juana Diez: Innovator in Antiviral Research

Introduction

Juana Diez is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of antiviral research, particularly through her innovative work on yeast genes that affect viral replication. Her research has the potential to lead to groundbreaking advancements in the development of virus-resistant organisms.

Latest Patents

Juana Diez holds a patent for an antiviral agent that comprises an altered MAB1, MAB2, MAB3, or OLE1 gene, along with gene homologs or related genes. This invention outlines a method for creating a virus-resistant organism by developing a transgenic organism that incorporates these antiviral agents. The implications of her work could be transformative in combating viral infections.

Career Highlights

Throughout her career, Juana has worked with notable organizations such as the Wisconsin Alumni Research Foundation and Twincore, Zentrum für Experimentelle und Klinische Infektionsforschung GmbH. Her experience in these institutions has allowed her to collaborate with leading experts in the field of infectious diseases.

Collaborations

Juana Diez has collaborated with esteemed colleagues, including Paul G. Ahlquist and Masayuki Ishikawa. These partnerships have enriched her research and contributed to the advancement of antiviral strategies.

Conclusion

Juana Diez is a trailblazer in the field of antiviral research, with her innovative patent and collaborations paving the way for future advancements. Her work exemplifies the impact of scientific innovation on public health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…